Methyl 4-(difluoromethoxy)-3-hydroxybenzoate, 97%, 250mg

Niobium(V) oxide, min. 99.9%, 50 g, plastic packaging.

8-Bromo-2H-isoquinolin-3-one, 97.0%, 10g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-thiopyran 1,1-dioxide, 98+%, 250mg

(S)-2-Aminobut-3-enoic acid hydrochloride, 95.0%, 5g

3-Methylglutaric Acid>99.0%(T)25g

5-Bromo-7-methyl-1-benzofuran-3-carboxylic acid, 95%, 50mg

TERT-BUTYL 1'-METHYL-5'-OXO-1',5',6',7'-TETRAHYDROSPIRO[PIPERIDINE-4,4'-PYRROLO[2,3-C]PYRIDINE]-1-CARBOXYLATE, 95.0%, 250mg

1H-Pyrazolo[3,4-c]pyridine, 95.0%, 1g

(S)-5-(1,3-Bis(tert-butoxycarbonyl)guanidino)-2-((tert-butoxycarbonyl)amino)pentanoic acid, 95.0%, 250mg

1-(4-Nitrophenyl)imidazole, 98.0%, 25g

Cyclohexanesulfinic acid sodium salt, 95%, 250mg

8-Methoxy-4-methylbenzo[g]coumarin>98.0%(HPLC)100mg